Commonwealth Equity Services’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30K Sell
21,111
-4,989
-19% -$7.09K ﹤0.01% 4200
2025
Q1
$42K Sell
26,100
-2,780
-10% -$4.47K ﹤0.01% 4081
2024
Q4
$104K Sell
28,880
-6,290
-18% -$22.7K ﹤0.01% 3897
2024
Q3
$200K Sell
35,170
-2,927
-8% -$16.6K ﹤0.01% 3703
2024
Q2
$176K Sell
38,097
-905
-2% -$4.18K ﹤0.01% 3678
2024
Q1
$319K Buy
39,002
+22,692
+139% +$186K ﹤0.01% 3218
2023
Q4
$92K Buy
16,310
+839
+5% +$4.73K ﹤0.01% 3685
2023
Q3
$29K Buy
15,471
+61
+0.4% +$114 ﹤0.01% 3707
2023
Q2
$42K Hold
15,410
﹤0.01% 3684
2023
Q1
$48 Buy
15,410
+1,212
+9% +$4 ﹤0.01% 3584
2022
Q4
$83K Buy
14,198
+305
+2% +$1.78K ﹤0.01% 3443
2022
Q3
$121K Sell
13,893
-817
-6% -$7.12K ﹤0.01% 3328
2022
Q2
$110K Buy
+14,710
New +$110K ﹤0.01% 3349